SpringWorks Therapeutics, Inc.: Investors Investigation

Investigation

Continous Holding
January 1, 2021 to August 15, 2022

Proposed Claim
Breach of Fiduciary Duty

This is a confidential investigation of whether certain directors & officers of SpringWorks Therapeutics, Inc. (SWTX) breached their fiduciary duties to SpringWorks and its shareholders.

SpringWorks investors and shareholders are encouraged to contact the law firm below for additional information.

Main Event

Annual Meeting

04/08/2022

SEC Filing

SpringWorks Therapeutics, Inc. files its DEF 14A proxy materials with the SEC for its 2022 annual shareholder meeting.

“The purpose of the Annual Meeting is the following:

1. To elect three Class III directors to our Board of Directors, each to serve until the 2025 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal;

2. To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022;

3. To approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers, or Say-on-Pay; and

4. To transact any other business properly brought before the Annual Meeting or any adjournment or postponement of the Annual Meeting.“

See more on Factual Timeline

Resolution

We have marked this investigation as closed.

Why was the case resolved?

The stockholders annual meeting took place.
On 05/20/2022 the company issued the following statement:

On May 19, 2022, SpringWorks Therapeutics, Inc. (the “Company”) held its annual meeting of stockholders to consider and vote on the proposals set forth below, each of which is described in greater detail in the Company’s definitive proxy statement filed with the U.S. Securities and Exchange Commission on April 8, 2022. The final voting results are set forth below.

Source

Form 8-K

Investigation

SpringWorks Therapeutics, Inc.

Investigation

Annual Meeting

SEC Filing

Resolution

Why was the case resolved?

Source

Factual Timeline

More

LegalZoom.com, Inc. (LZ)

Kewaunee Scientific Corporation (KEQU)

Builders FirstSource, Inc. (BLDR)

Amicus Therapeutics, Inc. (FOLD)

BioXcel Therapeutics, Inc. (BTAI)

Inari Medical, Inc. (NARI)

Privacy Policy

© Copyright 2025 Brios Services LLC

Terms & Conditions